A method for stimulating the proliferation of pluriopotential stem cells in a mammal comprising administration of pregnancy related compounds human chorionic gonadotropin (hCG), luteinizing hormone (LH) or prolactin. Further, the pregnancy related compounds are used in the treatment of heart, liver or kidney tissue or organs experiencing cellular damage due to injury or disease.